Establishment of a protocol for preventive vaccination against equine insect bite hypersensitivity.

The research article discusses the establishment of a vaccination protocol against equine insect bite hypersensitivity (IBH). The vaccination includes intralymphatic injection of r-Culicoides allergens, and the study compares this method to subcutaneous injection, finding both produced similar immunity, suggesting subcutaneous could be an option due to its simplicity.

Equine Insect Bite Hypersensitivity (IBH)

• IBH is a seasonal skin inflammation in horses, triggered by IgE-mediated reactions to the bites of Culicoides midges. The allergic reactions manifest in an imbalance of T-cell subsets, causing symptoms.
• Although the causative species of midges is not present in Iceland, Icelandic horses exported to other geographical locations exhibit a high prevalence of IBH, suggesting a genetic predisposition to the condition.

Intralymphatic Vaccination

• To combat IBH, the researchers developed a vaccination protocol. The vaccine, composed of r-Culicoides allergens in conjunction with Aluminum hydroxide (alum) and monophosphoryl lipid A (MPLA) adjuvants, aims to provoke a Th1/regulatory T-cell response.
• This vaccination is administered intralymphatically (i.l.), that is, directly into the lymphatic system of the horse. This method is believed to be efficient in summoning an adequate immune response.

Comparative Study – Intralymphatic and Subcutaneous Vaccination Methods

• The study involved 12 healthy Icelandic horses, vaccinated either intralymphatically or subcutaneously. The vaccination was administered three times over twelve weeks.
• Post-vaccination, analyses were conducted to measure serum antibody levels and the cytokine profile following in vitro re-stimulation of Peripheral Blood Mononuclear Cells (PBMC).
• The results showed comparable allergen-specific IgG antibodies being induced in both vaccination methods. These antibodies demonstrated similar efficacy in blocking the binding of IgE from IBH-afflicted horses to the allergens.

Results and Conclusion

• Upon re-stimulation of PBMC, the anti-inflammatory cytokine IL-10 was induced in the horses. Horses vaccinated intralymphatically produced more IFN-γ (responsible for Th1 response) and less IL-4 (which stimulates Th2 response) compared to subcutaneously injected horses. However, the difference was not statistically significant.
• Therefore, the researchers concluded that subcutaneous injection, being simpler to administer, might be a suitable alternative method for IBH immunotherapy, without significant compromise on the desired immune response.